Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Deykin Aaron Sells 895 Upstream Bio Shares at $5.49

Deykin Aaron sold 895 shares of Upstream Bio (NASDAQ: UPB) at $5.49 per share on Sept. 16, 2026. The transaction left Aaron with 32,302 shares, while the sale represented about 2.7% of his previous holding in Upstream Bio.

Vinay Lochav | 18 September 2026

Raymond Debbane Holds 675,000 Yarrow Bioscience (NASDAQ: YARW) Shares

Raymond Debbane holds 675,000 shares of Yarrow Bioscience, Inc. (NASDAQ: YARW), equal to 7.2% of the class. The ownership date is September 11, 2026. The stated purpose excludes seeking to change or influence control of Yarrow Bioscience.

Vinay Lochav | 18 September 2026

Ameresco (NYSE: AMRC) Co-President Sells 592 Shares at $22.46

Ameresco, Inc. (NYSE: AMRC) is an Engineering & Construction company. The sale occurred on 15 September 2026. Maltezos Louis P’s reported post-transaction holding was 33,628 shares. The reported price was $22.46 for each of the 592 shares sold. The transaction represented about 1.7% of …

Vinay Lochav | 18 September 2026

Travere Therapeutics (NASDAQ: TVTX) Reports September 15 Option Exercise and Share Sales

Travere Therapeutics, Inc. (NASDAQ: TVTX) is a Pharmaceuticals: Major company. Cline Christopher R. its CHIEF FINANCIAL OFFICER, exercised options covering 20,000 shares at $17.44 per share on 15 September 2026. The exercise left him with 138,016 shares, representing about 14.5% of his resulting share …

Vinay Lochav | 18 September 2026

Tyra Biosciences (NASDAQ: TYRA) Insider Buys 9.08M Derivative Securities

Tyra Biosciences, Inc. (NASDAQ: TYRA) is a biotechnology company. RA Capital Management, L.P. purchased 9,078,529 derivative securities in Tyra Biosciences at $22.03 per share on Sep. 15, lifting its resulting position to 11,616,986 derivative securities.

Vinay Lochav | 18 September 2026

Fuhrman Alan Holds 37,115 Tyra Biosciences Shares After Award

Fuhrman Alan received 951 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 each on 15 September 2026, leaving him with 37,115 shares. The transaction represented about 2.6% of his resulting holding. Alan is Tyra Biosciences’ Chief Financial Officer.

Vinay Lochav | 18 September 2026

Rueb Yuliya Awarded 2,925 Tyra Biosciences Shares at $9.13

Rueb Yuliya received 2,925 shares of Tyra Biosciences, Inc. (NASDAQ: TYRA) at $9.13 per share on 15 September 2026. The award left Yuliya with 11,258 Tyra Biosciences shares, while the transaction represented about 26.0% of the resulting holding.

Vinay Lochav | 18 September 2026

Posard Matthew L.: Halozyme Therapeutics Director Sells 18,996 Shares at Up to $108.99

Halozyme Therapeutics director Posard Matthew L. sold 18,996 shares on 16 September 2026 through four transactions, with prices ranging from $106.13 to $108.99 per share. His reported ownership after the sales was 58,839 shares. The disclosed transaction represented about 24.4% of his prior shares …

Vinay Lochav | 18 September 2026

Quanterix Corp (NASDAQ: QTRX) Adds 260,315 Derivative Securities in Insider Award

Quanterix Award Adds 260,315 Derivative Securities

Vinay Lochav | 18 September 2026

Sikri Vishal Awarded 257,731 Myriad Genetics Shares at $0

Sikri Vishal was awarded 257,731 shares of Myriad Genetics Inc at $0 per share. The ownership record also lists 93,493 shares held directly or indirectly by Vishal.

Vinay Lochav | 18 September 2026
Support

Hi! How can we help you today?

Loading…